Ann Samnegård

2.0k total citations
27 papers, 1.5k citations indexed

About

Ann Samnegård is a scholar working on Immunology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ann Samnegård has authored 27 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Epidemiology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ann Samnegård's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Protease and Inhibitor Mechanisms (5 papers). Ann Samnegård is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Protease and Inhibitor Mechanisms (5 papers). Ann Samnegård collaborates with scholars based in Sweden, United Kingdom and United States. Ann Samnegård's co-authors include Anders Hamsten, Per Eriksson, Per Tornvall, Susanna Boquist, Angela Silveira, Carl-Göran Ericsson, Pia Lundman, Christer Ericsson, William L. McPheat and Lars‐Olof Hansson and has published in prestigious journals such as Circulation, Nature Genetics and PLoS ONE.

In The Last Decade

Ann Samnegård

27 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ann Samnegård Sweden	22	532	405	355	314	221	27	1.5k
Roslynn A. Stirzaker United States	8	848 1.6×	475 1.2×	555 1.6×	263 0.8×	149 0.7×	8	1.8k
Camilla Smith Norway	23	705 1.3×	503 1.2×	647 1.8×	308 1.0×	174 0.8×	28	1.9k
Haitao Yuan China	12	741 1.4×	187 0.5×	559 1.6×	306 1.0×	219 1.0×	21	2.3k
Lindsey A. MacFarlane United States	21	756 1.4×	334 0.8×	526 1.5×	156 0.5×	164 0.7×	46	2.1k
Dirk Lievens Germany	19	1.4k 2.6×	347 0.9×	555 1.6×	303 1.0×	205 0.9×	22	2.3k
Raquel López‐Mejías Spain	26	715 1.3×	243 0.6×	526 1.5×	162 0.5×	108 0.5×	130	2.0k
Sandra Abramowicz United States	16	843 1.6×	326 0.8×	682 1.9×	172 0.5×	296 1.3×	19	1.8k
Randolph Hutter United States	18	320 0.6×	146 0.4×	374 1.1×	303 1.0×	144 0.7×	31	1.2k
Louisa M.S. Gerhardt United States	12	957 1.8×	316 0.8×	677 1.9×	371 1.2×	129 0.6×	19	1.8k
Nelli Shushakova Germany	26	409 0.8×	154 0.4×	481 1.4×	125 0.4×	163 0.7×	50	1.5k

Countries citing papers authored by Ann Samnegård

Since Specialization

Citations

This map shows the geographic impact of Ann Samnegård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Samnegård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Samnegård more than expected).

Fields of papers citing papers by Ann Samnegård

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Samnegård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Samnegård. The network helps show where Ann Samnegård may publish in the future.

Co-authorship network of co-authors of Ann Samnegård

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Samnegård. A scholar is included among the top collaborators of Ann Samnegård based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Samnegård. Ann Samnegård is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jernberg, Tomas, Ann Samnegård, Fredrik Johansson, et al.. (2024). Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarction. Cytokine. 182. 156696–156696. 5 indexed citations

Sundman, Eva, О. А. Овчинникова, Nikolai Scherbak, et al.. (2012). A CYP26B1 Polymorphism Enhances Retinoic Acid Catabolism and May Aggravate Atherosclerosis. Molecular Medicine. 18(4). 712–718. 27 indexed citations

Deleskog, Anna, Angela Silveira, Ann Samnegård, et al.. (2012). Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years. Atherosclerosis. 223(1). 223–229. 23 indexed citations

Ria, Massimiliano, Jacob Lagercrantz, Ann Samnegård, et al.. (2011). A Common Polymorphism in the Promoter Region of the TNFSF4 Gene Is Associated with Lower Allele-Specific Expression and Risk of Myocardial Infarction. PLoS ONE. 6(3). e17652–e17652. 18 indexed citations

Mälarstig, Anders, Angela Silveira, Dick Wågsäter, et al.. (2011). Plasma CD93 concentration is a potential novel biomarker for coronary artery disease. Journal of Internal Medicine. 270(3). 229–236. 34 indexed citations

Persson, Jonas, Johan Lindbäck, Claes Hofman‐Bang, et al.. (2011). Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome. EuroIntervention. 6(9). 1046–1052. 19 indexed citations

Bennermo, Marie, Margareta Nordin, Pia Lundman, et al.. (2010). Genetic and Environmental Influences on the Plasma Interleukin-6 Concentration in Patients with a Recent Myocardial Infarction: A Case–Control Study. Journal of Interferon & Cytokine Research. 31(2). 259–264. 34 indexed citations

Olofsson, Peder S., Yuri Sheikine, Kenbugul Jatta, et al.. (2009). A Functional Interleukin-1 Receptor Antagonist Polymorphism Influences Atherosclerosis Development The Interleukin-1.BETA.:Interleukin-1 Receptor Antagonist Balance in Atherosclerosis. Circulation Journal. 73(8). 1531–1536. 53 indexed citations

Sjögren, Per, Gunilla Nordin Fredrikson, Ann Samnegård, et al.. (2008). High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. European Heart Journal. 29(18). 2218–2226. 85 indexed citations

10.

Samnegård, Ann, Johannes Hulthe, Angela Silveira, et al.. (2008). Gender specific associations between matrix metalloproteinases and inflammatory markers in post myocardial infarction patients. Atherosclerosis. 202(2). 550–556. 34 indexed citations

11.

Mannila, Maria, Rehana Sultana Lovely, Steven C. Kazmierczak, et al.. (2007). Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors. Journal of Thrombosis and Haemostasis. 5(4). 766–773. 73 indexed citations

12.

Samnegård, Ann, Angela Silveira, Per Tornvall, et al.. (2006). Lower serum concentration of matrix metalloproteinase‐3 in the acute stage of myocardial infarction. Journal of Internal Medicine. 259(5). 530–536. 27 indexed citations

13.

Hulthe, Johannes, William L. McPheat, Ann Samnegård, et al.. (2006). Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis. 188(2). 450–454. 71 indexed citations

14.

Samnegård, Ann, Pia Lundman, Per Tornvall, et al.. (2005). Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR‐PSOX gene. Journal of Internal Medicine. 257(5). 415–422. 39 indexed citations

15.

Samnegård, Ann, Angela Silveira, Pia Lundman, et al.. (2005). Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction. Journal of Internal Medicine. 258(5). 411–419. 96 indexed citations

16.

Sheikine, Yuri, Lennart Nilsson, Ann Samnegård, et al.. (2005). Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease. Atherosclerosis. 188(2). 462–466. 48 indexed citations

17.

Wang, Xiaosong, Massimiliano Ria, Peter M. Kelmenson, et al.. (2005). Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nature Genetics. 37(4). 365–372. 224 indexed citations

18.

Eriksson, Per, Pia Lundman, Ann Samnegård, et al.. (2005). Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thrombosis and Haemostasis. 93(3). 570–577. 34 indexed citations

19.

Kovacs, Alexander, Fiona Green, Lars‐Olof Hansson, et al.. (2004). A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis. 178(1). 193–198. 106 indexed citations

20.

Korstanje, Ron, Per Eriksson, Ann Samnegård, et al.. (2004). Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis. 177(2). 443–450. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact